Last update July 29, 2024
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
プロカインアミド塩酸塩 is Procainamide Hydrochloride in Japanese.
Is written in other languages:プロカインアミド塩酸塩 is also known as
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Procainamide is a class Ia antiarrhythmic with properties similar to those of quinidine. It is used to treat life-threatening ventricular arrhythmias. Oral or intramuscular administration in doses every 3, 6 or 12 hours.
Excreted in breast milk in clinically insignificant amount: a single study in one mother. (Pittard 1983)
Expert authors consider that the use of this medication during lactation is probably compatible. (Hale, Tan 2001, Cox 1993)
American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs: compatible with Breastfeeding. (WHO 2002)